Updated:
Red Cell Partners
We are a venture studio building, launching, and scaling technology-led companies in healthcare, cyber, and national security.
Red Cell Partners
We are a venture studio building, launching, and scaling technology-led companies in healthcare, cyber, and national security.
General information
Firm type
Venture Studio
Year founded
2020
AUM
Undisclosed
Location
Region
North America
Country
United States
City
McLean
Corporate office
McLean, VA, United States
Principals
Grant Verstandig
Founder, Chairman, & CEO
David Silverman
Team
Veronica Daigle
Team
George Barnes
Team
Sector focus
Frequently asked questions
Who leads Red Cell Partners and makes the investment decisions?
Grant Verstandig founded the firm and serves as Chairman and CEO. The firm's website lists him alongside senior leaders David Silverman, Veronica Daigle, and George Barnes. A formal Investment Committee approves funding for each internal incubation before the company is formally stood up, as described in the firm's own process documentation.
Is Red Cell Partners a venture capital fund or a venture studio?
It operates exclusively as a venture studio. Rather than investing in pre-existing startups, Red Cell incubates companies internally: it generates ideas, recruits operators, funds the initial build phase through its Investment Committee, and then prepares those companies to raise external capital.
How does Red Cell source its ideas and deal flow?
All deal flow is internally generated. The firm identifies urgent, unmet needs in healthcare, cyber, and national security, then stands up new companies from scratch rather than sourcing deals in the open market. This in-sourced model is central to its stated mission of bringing rapid innovation to overburdened government-adjacent markets.
Which sectors does Red Cell explicitly avoid?
Red Cell explicitly focuses on three verticals — healthcare, cyber, and national security. It does not invest in consumer technology, enterprise SaaS outside those sectors, fintech, climate, or generalist venture opportunities.
What is the firm's relationship with the U.S. government and defense agencies?
The firm's name invokes the CIA's post-9/11 Red Cell concept, and its strategy targets federal and defense modernization. It builds companies for mission-critical government markets, but it operates as a private, for-profit entity, not a government contractor. The model allows it to pursue procurement-shaped opportunities while retaining venture-style equity upside.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: